| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.13 | 8e-06 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.14 | 8e-06 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.15 | 9e-06 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.14 | 1e-05 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | 0.21 | 2e-05 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | -0.15 | 2e-05 |
| mRNA | selumetinib:MK-2206 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.15 | 4e-05 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.14 | 8e-05 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | 0.13 | 8e-05 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0001 |